Literature DB >> 1821324

Occurrence, clinical behaviour and management of Kaposi's sarcoma in Zambia.

A C Bayley1.   

Abstract

The incidence of HIV related KS has increased 50-fold since it was first recognized in Zambia in 1983. The mean age at diagnosis is 35 years for men and 28 years for women, with a sex ratio of M:F = 5:1. The most common symptoms and signs are weight loss, symmetrical lymphadenopathy, oral plaques, skin plaques in a central distribution, oedema and cough with dyspnoea. Biopsy is needed to confirm the diagnosis if disease is confined to lymph nodes. Objective regression occurs in 80% of patients receiving adequate doses of actinomycin D and vincristine (median survival time greater than 3 years for stage I or II disease and 7.5 months for stage III); epirubicin with vincristine was more effective in a phase II trial. Both treatments give good relief of symptoms, allowing patients to return to work. Clinical, histological and biological features of HIV related KS do not support conclusively its classification as a "malignant tumour". Heterosexual and perinatal transmission of HIV in Africa ensures that KS affects families, not just individuals.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1821324

Source DB:  PubMed          Journal:  Cancer Surv        ISSN: 0261-2429


  8 in total

1.  HIV and cancer in Africa: mutual collaboration between HIV and cancer programs may provide timely research and public health data.

Authors:  Sam M Mbulaiteye; Kishor Bhatia; Clement Adebamowo; Annie J Sasco
Journal:  Infect Agent Cancer       Date:  2011-10-17       Impact factor: 2.965

2.  Monocytes in Kaposi's sarcoma lesions are productively infected by human herpesvirus 8.

Authors:  C Blasig; C Zietz; B Haar; F Neipel; S Esser; N H Brockmeyer; E Tschachler; S Colombini; B Ensoli; M Stürzl
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

Review 3.  The viral etiology of AIDS-associated malignancies.

Authors:  Peter C Angeletti; Luwen Zhang; Charles Wood
Journal:  Adv Pharmacol       Date:  2008

4.  The Zambia Children's KS-HHV8 Study: rationale, study design, and study methods.

Authors:  Veenu Minhas; Kay L Crabtree; Ann Chao; Janet M Wojcicki; Adrian M Sifuniso; Catherine Nkonde; Chipepo Kankasa; Charles D Mitchell; Charles Wood
Journal:  Am J Epidemiol       Date:  2011-03-28       Impact factor: 4.897

5.  Kaposi sarcoma in Germany.

Authors:  P Matondo; S Sivapalan
Journal:  Genitourin Med       Date:  1995-04

6.  Mortality among HIV-1- and human herpesvirus type 8-affected mother-infant pairs in Zambia.

Authors:  Janet Wojcicki; Mulindi Mwanahamuntu; Veenu Minhas; Boris Djokic; Chipepo Kankasa; Winslow Klaskala; Brad Brayfield; Saul Phiri; Charles Wood; Charles D Mitchell
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-09       Impact factor: 4.254

7.  Early childhood infection by human herpesvirus 8 in Zambia and the role of human immunodeficiency virus type 1 coinfection in a highly endemic area.

Authors:  Veenu Minhas; Kay L Crabtree; Ann Chao; Tendai J M'soka; Chipepo Kankasa; Marc Bulterys; Charles D Mitchell; Charles Wood
Journal:  Am J Epidemiol       Date:  2008-05-30       Impact factor: 4.897

Review 8.  Epidemiology and transmission of Kaposi's sarcoma-associated herpesvirus.

Authors:  Veenu Minhas; Charles Wood
Journal:  Viruses       Date:  2014-11-04       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.